Showing 5,241 - 5,260 results of 30,064 for search '(( 50 ((teer decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( 2 step decrease ))', query time: 0.80s Refine Results
  1. 5241

    Bar graph showing proportion of NADCs. by Raymond Atwine (18574812)

    Published 2025
    “…The Commonest ADC was Kaposi Sarcoma (KS) while the commonest NADC was Squamous cell carcinoma, Not otherwise specified. Age above 50 years was associated with a significantly reduced risk of ADCs (OR: 0.11; 95% CI: 0.03–0.43; p value: 0.002). …”
  2. 5242

    Baseline characteristics of study participants. by Raymond Atwine (18574812)

    Published 2025
    “…The Commonest ADC was Kaposi Sarcoma (KS) while the commonest NADC was Squamous cell carcinoma, Not otherwise specified. Age above 50 years was associated with a significantly reduced risk of ADCs (OR: 0.11; 95% CI: 0.03–0.43; p value: 0.002). …”
  3. 5243

    S1 Data - by Shane R. McClafferty (19434460)

    Published 2024
    “…Once pups had reached adolescence (PND 50), researchers tested for differences in anxiety, activity, and social behavior using elevated plus-maze, open field habituation, a three-chamber social interaction, and a social discrimination task. …”
  4. 5244
  5. 5245
  6. 5246
  7. 5247
  8. 5248
  9. 5249
  10. 5250
  11. 5251
  12. 5252

    S4 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  13. 5253

    S6 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  14. 5254

    S3 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  15. 5255

    S9 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  16. 5256

    S7 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  17. 5257

    S1 Raw data - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  18. 5258

    S8 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  19. 5259

    S2 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  20. 5260

    S1 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”